With 2.98 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.23 million shares. The 52-week range on LUNG shows that it touched its highest point at $14.60 and its lowest point at $5.46 during that stretch. It currently has a 1-year price target of $11.67. Beta for the stock currently stands at 0.65.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of LUNG was up-trending over the past week, with a rise of 25.25%, but this was up by 41.84% over a month. Three-month performance surged to 38.49% while six-month performance rose 30.27%. The stock lost -38.69% in the past year, while it has gained 29.31% so far this year. A look at the trailing 12-month EPS for LUNG yields -1.44 with Next year EPS estimates of -1.43. For the next quarter, that number is -0.39. This implies an EPS growth rate of -6.66% for this year and 6.73% for next year. EPS is expected to grow by 5.22% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -19.80%.
Float and Shares Shorts:
At present, 39.49 million LUNG shares are outstanding with a float of 34.28 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for LUNG since 4 analysts follow the stock currently. There are 3 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$1.53808 being high and -$1.56844 being low. For LUNG, this leads to a yearly average estimate of -$1.55832. Based on analyst estimates, the high estimate for the next quarter is -$0.36 and the low estimate is -$0.41. The average estimate for the next quarter is thus -$0.39.
